Medical/Pharmaceuticals
DEDAKJ responses to India Today's report on misinterpretation of its product quality
NEW DELHI, May 4, 2021 /PRNewswire/ --A few days ago, Indian television network India Today alleged that the DEDAKJ oxygen concentrators supplied toIndia by a China-based Sino-German Joint Venture under its exclusive agency brand are counterfeit and are shoddy products that use humidifiers rather...
2021-05-04 08:33
2375
Cleveland Clinic, Lifebanc and Transplant Connect Develop Automated Donor Referral Process
New system streamlines organ donation process, helping to save, heal more lives through donation, transplantation CLEVELAND, May 4, 2021 /PRNewswire/ -- Cleveland Clinic, Lifebanc and Transplant Connect have designed and launched a fully automated donor referral system to streamline the process ...
2021-05-04 00:58
1665
MindMaze Expands Global Reach of Digital Neurotherapeutics Portfolio with Four New Partnerships
Bringing the future of brain repair for stroke, Parkinson's, and other neurological conditions to patients inLatin America, Europe and Middle East LAUSANNE, Switzerland, May 3, 2021 /PRNewswire/ -- MindMaze Healthcare, a global pioneer in the multibillion-dollar digital neurotherapeutics market,...
2021-05-03 23:49
1913
IVM-MS2, 'The Most Compact All-in-One IntraVital Two-Photon Microscopy System in the World'
IVIM Technology, Inc. has released the most compact all-in-one intravital two-photon microscope, "IVM-MS2." IVIM Technology, Inc. is the world's first start-up that commercializes all-in-one integrated intravital microscopy equipment. Our equipment uses innovative intravital microscopy (IVM) tech...
2021-05-03 23:47
1622
Galmed Announces Approval of IND Application in China for Aramchol for the Treatment of NASH & Fibrosis in the Global Phase 3 ARMOR Registrational Study
China to Join Galmed's Phase 3 ARMOR Registrational Study for the Treatment of NASH & Fibrosis TEL AVIV, Israel, May 3, 2021 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and inflammatory di...
2021-05-03 20:30
4390
Global Transfusion Medicine Leader Ortho Clinical Diagnostics Launches Next Gen ORTHO VISION® Swift Platform
ORTHO VISION is the leading choice for blood banks RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO VISION® Swift and ORTHO VISION® Max Swi...
2021-05-03 20:00
3663
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction
VANCOUVER, BC, May 3, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (CSE: BIOV.CN) (FRA: 5LB) (OTC: BVAXF) ("BioVaxys" or "Company") announced today that it has signed the definitive exclusive bioproduction agreement ("Agreement") with BioElpida S.A.S. ("BioElpida") of Lyon,Franc...
2021-05-03 20:00
3184
Swift support for India - Fosun's additional aid of 100,000 KN95 masks arrived in Mumbai
HONG KONG and SHANGHAI and MUMBAI, India, May 3, 2021 /PRNewswire/ -- On May 2 morning, Fosun responded swiftly to India's plight and a new batch of medical protective supplies - 100,000 KN95 masks – has arrived inMumbai from Shanghai. This is another rapid aid following Fosun's donation of 5,000...
2021-05-03 17:18
3774
FDI World Dental Federation Sustainability in Dentistry initiative unites eco-conscious dental industry partners around a common aim
GENEVA, May 3, 2021 /PRNewswire/ -- FDI World Dental Federation (FDI) today launched a new initiative, with commitments from four founding industry partners – Colgate, Dentsply-Sirona, GSK Consumer Healthcare, and TePe – to lead the charge on sustainability in dentistry. Over the next two years ...
2021-05-03 17:00
2874
New members elected to Occlutech Board of Directors
Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board SCHAFFHAUSEN, Switzerland, May 3, 2021 /PRNewswire/ -- Occlutech Holding AG ( "Occlutech") today announ...
2021-05-03 15:00
2580
Ultrahuman Launches Mac App, Trends on #1 on App Store
You can now follow your favourite workout routine, get to deep work with LoFi music, or do a quick meditation session from the comfort of your Mac BENGALURU, India, May 3, 2021 /PRNewswire/ -- Global health and fitness platformUltrahuman officially launched its Mac app to help users meditate, get...
2021-05-03 08:55
1777
Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer is Expected to Alleviate the Oxygen Shortage Crisis during COVID-19 Pandemic
SHANGHAI, May 1, 2021 /PRNewswire/ -- In June, 2020, an academic paper on patients with COVID-19 inhaling hydrogen oxygen mixed gas produced by Asclepius Meditec's Hydrogen Oxygen Generator with Nebulizer was published in the Journal of Thoracic Disease. The multicenter, and open-label clinical t...
2021-05-01 17:17
4840
New focus on COVID-19 infection and the future of human reproduction
SINGAPORE, May 1, 2021 /PRNewswire/ -- A review of global research of the impact of COVID-19 on human fertility suggests males are more susceptible than females to reproductive tract infection from the virus. A summary of international studies on the effect of COVID-19 on fertility was presente...
2021-05-01 13:00
2866
Tessa Therapeutics Announces Enrollment of 12 Patient Pilot Cohort in its Relapsed or Refractory Hodgkin Lymphoma Phase 2 Study
82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPORE, April 30, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors...
2021-04-30 18:00
1996
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic
Commercial trademark application FILED for CoviDTH® diagnostic cancer vaccine platform patent coverageexpanded to NOW include over 12 tumor types VANCOUVER, B.C., April 29, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) ("BioVaxys" or "the Company"), the world ...
2021-04-29 20:56
3101
Artificial Intelligence helps IVF patients avoid invasive embryo genetic testing
SAN FRANCISCO, April 29, 2021 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A geneti...
2021-04-29 19:47
2281
2021, a turning point for PQE Group: no more internal hierarchy and a hiring plan of 550 new employees
FLORENCE, Italy, April 29, 2021 /PRNewswire/ -- PQE Group
2021-04-29 18:18
962
Hilco Industrial Acquires All Machinery & Equipment from Legacy Pharmaceutical Switzerland
BASEL, Switzerland, April 29, 2021 /PRNewswire/ -- Hilco Industrial Acquisitions, anAmsterdam-based Industrial Asset Disposition and Acquisition Company, acquired all Machinery & Equipment from theSwiss-based CMO Legacy Pharmaceuticals. After several years of expansion, the Swiss company was forc...
2021-04-29 13:04
1769
Antengene Announces XPO1 Inhibitor Selinexor Prescribed for the First Time in the Pilot Zone of Hainan Province and Authorized to be Expanded Beyond the Pilot Zone for Outpatient Treatment
SHANGHAI and HONG KONG, April 29, 2021 /PRNewswire/ -- With the official release and implementation ofthe Overall Plan for the Construction of Hainan Free Trade Port, patient can now access global innovative medicines in mainland China. Recently, the global first-in-class selective inhibitor of n...
2021-04-29 08:34
3245
Alphamab announced PD-L1/CTLA-4 bispecific antibody KN046 will enter new Phase II clinical trial in combination with Pfizer's Inlyta® (axitinib)
SUZHOU, China, April 29, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced that it has entered into a clinical trial collaboration and supply agreement with Pfizer to evaluate the efficacy and safety of KN046 in combination with Inlyta® (axitinib) for the first-line treatment ...
2021-04-29 08:00
4691
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9273
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7751